Find investors
← Back to all investors
JC
ResearchedAngel Investors

Joo Yong Chung

Managing Director & Head of Private Equity Department

Angel InvestorsSeed Round
Pitch Joo

Get their honest, personalized take on your startup.

Sign in to pitch Joo

At a glance

Full Name
Joo-Yong Chung
Title
Executive Vice President and Head of M&A at Hanwha Aerospace; former Managing Director and Head of PE at UTC Investment
Firm
UTC Investment
Firm Type
Venture capital and private equity investment manager
Investment Stage
Seed, Series A, Series B, growth capital, buyout/M&A
Target Company Profile
Korean and global companies where UTC can add post-investment value through active portfolio management, market access, operational improvement, and exit planning
Sector Focus
Bio/healthcare, lifestyle, IT/semiconductor; current corporate M&A work also spans aerospace, defense, shipbuilding, satellite communications, and strategic minority investments
Geographic Focus
Primarily South Korea, with selected global investments
Location
Seoul, South Korea

Background

Joo-Yong Chung is a South Korean investment and corporate-development executive. REC Silicon’s 2024 annual report lists her as Head of M&A and Executive Vice President at Hanwha Aerospace, with prior roles as Managing Director and Head of PE at UTC Investment and Daesang Group from 2018 to 2021, Director at MBK Partners from 2008 to 2017, and Vice President at The Carlyle Group from 2004 to 2008.

Her earlier background includes strategy consulting and public-sector work. Equilar’s biography, sourced to Eutelsat Communications, says she worked at Boston Consulting Group in Seoul and Boston and as a senior government official at Korea’s National Statistics Office before moving into private equity. The same source says she has a B.A. in Economics from Seoul National University and an MBA from Harvard Business School.

At UTC Investment, Chung led private equity activity at a Seoul-based firm founded in 1988. UTC describes its investment approach as combining venture capital, growth capital, and buyout experience, with active “value-up” work in bio/healthcare, lifestyle, and IT/semiconductor.

Since joining Hanwha Group in August 2022, Chung has focused on M&A, strategic minority investments, bolt-on acquisitions, deal execution, and post-merger integration. She also serves in governance roles connected to Hanwha’s strategic holdings: REC Silicon’s 2024 annual report lists her as Deputy Chair, and Eutelsat announced in March 2024 that Hanwha Systems UK Ltd, represented by Chung, joined Eutelsat Communications’ board.

Investment Thesis & Focus

  • UTC Investment frames its core investing philosophy around transparency, integrity, and “long-term value creation,” with an emphasis on a virtuous cycle among portfolio companies, capital markets, and industries.
  • The firm’s stated operating style is “Value-Up & Change Capital”: it seeks to identify potential value and then create additional value through post-investment activity.
  • UTC focuses on bio/healthcare, lifestyle, and IT/semiconductor, and its portfolio page shows investments across domestic and global companies.
  • UTC’s stage coverage includes early venture rounds such as Seed, Series A, and Series B, plus Growth Cap and M&A/control transactions.
  • Chung’s personal background is weighted toward buyouts and complex M&A: Carlyle, MBK Partners, UTC PE, Daesang Group, and now Hanwha Aerospace corporate M&A.
  • For founders, the strongest fit is likely a company in UTC’s focus sectors where a Korean growth investor can help with commercialization, governance, follow-on financing, strategic partnerships, or exit readiness.

Notable Investments

  • Kurly / Market Kurly: Korean fresh-food morning-delivery platform; UTC lists Series B and Series C participation and notes Kurly was selected as a unicorn company in 2021.
  • Jeju Beer: Korean craft-beer company; UTC lists Series A and Series B participation and notes a KOSDAQ listing in May 2020.
  • ICTK Holdings: Semiconductor security and PUF technology company; UTC lists Series A through Series C participation.
  • Semifive: Korean semiconductor design-solutions company founded in 2019; UTC lists Seed and Series A participation.
  • PDC line Pharma: Off-the-shelf dendritic-cell cancer vaccine developer; UTC lists it in bio/healthcare.
  • LifeSemantics: Healthcare IT platform company; UTC lists it as a bio/healthcare portfolio company with IPO status.
  • JTNet: Korean VAN payments infrastructure company; UTC lists it as an M&A/control investment and describes post-acquisition business-improvement work.
  • Markpro: Patent annuity-payment management company; UTC says it acquired 100% control and supported restructuring, cost-system management, and overseas expansion.
  • Hanwha Philly Shipyard: Hanwha Systems and Hanwha Ocean completed a $100 million acquisition of Philly Shipyard in December 2024; Chung publicly thanked the Hanwha M&A team and advisors for the closing on LinkedIn.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.